ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 98 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 10.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,370,000 | +93.2% | 170,863 | -19.5% | 0.03% | +61.1% |
| Q3 2020 | $4,851,000 | -46.0% | 212,186 | -50.5% | 0.02% | 0.0% |
| Q2 2020 | $8,976,000 | +58.1% | 428,848 | +5.4% | 0.02% | +28.6% |
| Q1 2020 | $5,676,000 | -43.0% | 406,862 | -6.9% | 0.01% | -30.0% |
| Q4 2019 | $9,952,000 | +99.6% | 437,238 | +2.2% | 0.02% | +100.0% |
| Q3 2019 | $4,986,000 | -22.5% | 427,966 | -0.2% | 0.01% | -23.1% |
| Q2 2019 | $6,430,000 | +74.8% | 428,724 | +104.5% | 0.01% | -7.1% |
| Q1 2019 | $3,678,000 | +53.4% | 209,684 | +29.6% | 0.01% | +40.0% |
| Q4 2018 | $2,398,000 | -24.3% | 161,828 | +25.8% | 0.01% | -16.7% |
| Q3 2018 | $3,166,000 | – | 128,622 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |